May 27, 2016 1:19 am
Developed jointly by NBRI and CIMAP, the research units of CSIR situated at Lucknow, BGR-34 has been economically priced at Rs 5 per tablet as compared to the latest DPP4 inhibitors, globally.
June 03, 2014 5:33 pm
Metformin, the world's most widely used anti-diabetic drug, may slow ageing and increase lifespan, a new study suggests.
April 02, 2013 1:14 am
A novel anti-diabetic drug that lowers blood glucose levels by acting on the kidneys,instead of the liver or the pancreas,has been approved by the USFDA
October 28, 2010 11:54 pm
Drug Controller General of India (DCGI) is likely to take up the issue of a complete ban on the widely used anti-diabetic drug,rosiglitazone.
October 08, 2010 4:46 am
The Drug Controller General of India (DCGI) Thursday suspended manufacturing and import of the anti-diabetic drug Rosiglitazone.


